Exome Asset Management »

Catalyst Pharmaceutical Partners shares owned by Exome Asset Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 106k 16.81

More positions owned by Exome Asset Management

Dr Reddys Labs Adr (RDY)
Eli Lilly & Co. (LLY)
ImmunoGen
Cigna Corp (CI)
Celldex Therapeutics Com New (CLDX)
Tg Therapeutics (TGTX)
Rhythm Pharmaceuticals (RYTM)
Alpine Immune Sciences (ALPN)
Dex (DXCM)
Madrigal Pharmaceuticals (MDGL)
Cytokinetics Com New (CYTK)
Inhibrx (INBX)
Structure Therapeutics Sponsored Ads (GPCR)
Rocket Pharmaceuticals (RCKT)
Bridgebio Pharma (BBIO)

View all positions for Exome Asset Management

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
T. Rowe Price Associates
Henderson Group
Goldman Sachs Group
Charles Schwab Investment Management
LSV Asset Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners